Integrated Wealth Concepts’s Aethlon Medical AEMD Stock Holding History

Integrated Wealth Concepts’s Portfolio AEMD Stock Details AEMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12	Buy	+3	New	+$31	﹤0.01%	5881

Other funds holding AEMD

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SRL

Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Integrated Wealth Concepts's AEMD Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in Aethlon Medical (AEMD) in Q2 2026: 3 shares worth $12. The stake represents ﹤0.01% of the portfolio and ranks #5881 among its holdings.

16 funds tracked by Wall St. Rank hold AEMD as of Q2 2026.

Integrated Wealth Concepts held 3 shares of Aethlon Medical worth $12 as of Q2 2026.
Aethlon Medical was a new Integrated Wealth Concepts position in Q2 2026.
Aethlon Medical made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #5881 holding.
16 funds tracked by Wall St. Rank held Aethlon Medical as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.